These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29733878)

  • 1. Multi-step high-throughput conjugation platform for the development of antibody-drug conjugates.
    Andris S; Wendeler M; Wang X; Hubbuch J
    J Biotechnol; 2018 Jul; 278():48-55. PubMed ID: 29733878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of hydrophobic interaction chromatography for the separation of antibody-drug conjugates and its application towards quality by design.
    Andris S; Hubbuch J
    J Biotechnol; 2020 Jun; 317():48-58. PubMed ID: 32361022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing Solid-Phase to Enable High-Throughput, Site-Specific Conjugation and Dual-Labeled Antibody and Fab Conjugates.
    Puthenveetil S
    Methods Mol Biol; 2020; 2078():99-112. PubMed ID: 31643052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput oxidation screen of antibody-drug conjugates by analytical protein A chromatography following IdeS digest.
    Buecheler JW; Winzer M; Weber C; Gieseler H
    J Pharm Pharmacol; 2018 May; 70(5):625-635. PubMed ID: 29380379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of linker-drug on ion exchange chromatography separation of antibody-drug conjugates.
    Zhang Z; Zhou S; Han L; Zhang Q; Pritts WA
    MAbs; 2019; 11(6):1113-1121. PubMed ID: 31238787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
    Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
    Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
    J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of multiple LC-MS approaches for the comprehensive characterization of cysteine-linked ADCs.
    Wu G; Du J; Li M; Xu G; Fu Z; Liu Y; Zhang X; Wu G; Yu C; Wang J
    J Pharm Biomed Anal; 2024 Sep; 248():116331. PubMed ID: 38968868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical de-conjugation for investigating the stability of small molecule drugs in antibody-drug conjugates.
    Chen T; Su D; Gruenhagen J; Gu C; Li Y; Yehl P; Chetwyn NP; Medley CD
    J Pharm Biomed Anal; 2016 Jan; 117():304-10. PubMed ID: 26406314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Ring-Opening Reaction of Succinimide Linkers in ADCs.
    Zheng K; Chen Y; Wang J; Zheng L; Hutchinson M; Persson J; Ji J
    J Pharm Sci; 2019 Jan; 108(1):133-141. PubMed ID: 30458165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
    Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
    MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic reaction modeling for antibody-drug conjugate process development.
    Andris S; Seidel J; Hubbuch J
    J Biotechnol; 2019 Dec; 306():71-80. PubMed ID: 31557498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugations to Endogenous Cysteine Residues.
    Nadkarni DV
    Methods Mol Biol; 2020; 2078():37-49. PubMed ID: 31643048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated high-throughput buffer exchange platform enhances rapid flow analysis of antibody drug conjugates by high resolution mass spectrometry.
    Yang Y; Rao R; Valliere-Douglass J; Tremintin G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Mar; 1235():124007. PubMed ID: 38387340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-Specific Antibody-Drug Conjugation Using Microbial Transglutaminase.
    Dickgiesser S; Deweid L; Kellner R; Kolmar H; Rasche N
    Methods Mol Biol; 2019; 2012():135-149. PubMed ID: 31161507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
    Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
    MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
    Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.